On 27 October 2016
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 October 2016 to consider and approve the Company's Unaudited Financial Statements for Second Quarter/Half Year ended September 30, 2016 (Q2).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
